Establishing the Research Priorities of ADHD Professionals: An International Delphi Study

Overview

Journal J Atten Disord

Publisher Sage Publications

Specialty Psychiatry

Date 2024 Dec 25

PMID 39720846

Authors

Kate Stephens

Emma Sciberras

Matthew Bisset

Ainsley Summerton

David Coghill

Christel M Middeldorp

Leanne Payne

Mark A Bellgrove

Stephen V Faraone

Tobias Banaschewski

Jeffery H Newcorn

Stacey D Espinet

Iris Manor

Mohammed M J Alqahtani

Jeremy Varnham

Timothy J Silk

Affiliations

Soon will be listed here.

Abstract

Objectives: To determine ADHD research priorities from the perspective of ADHD professionals internationally.

Method: A two-stage modified Delphi design was used. In Stage 1 (qualitative), participants listed research questions relating to ADHD that they perceived to be most important ( = 132). In Stage 2 (quantitative), participants were then asked to rate each research question that was deemed appropriate (able to be researched and not already addressed by research) in terms of perceived importance ( = 180).

Results: Stage 1 generated 382 research questions with 10 broad areas identified for example, co-occurring conditions and treatment, etc. The top 20 most important questions related to ADHD in women/girls, long-term medication use, non-pharmacological interventions, ADHD measurement/rating scales, and efficacy of emotional regulation interventions.

Conclusion: These results can inform an ADHD research agenda which represents the views of the individuals from major ADHD professional groups internationally. Parallel work is needed focusing on research priorities from the perspective of ADHD consumers.

References

Coghill D, Banaschewski T, Cortese S, Asherson P, Brandeis D, Buitelaar J . The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG). Eur Child Adolesc Psychiatry. 2021; 32(8):1337-1361. PMC: 8532460. DOI: 10.1007/s00787-021-01871-x. View

Kovshoff H, Banaschewski T, Buitelaar J, Carucci S, Coghill D, Danckaerts M . Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale. J Child Adolesc Psychopharmacol. 2016; 26(6):537-47. PMC: 4991592. DOI: 10.1089/cap.2015.0218. View

Gaynes B, Christian R, Saavedra L, Wines R, Jonas D, Viswanathan M . Attention-deficit/hyperactivity disorder: identifying high priority future research needs. J Psychiatr Pract. 2014; 20(2):104-17. DOI: 10.1097/01.pra.0000445245.46424.25. View

Byrne S, Wake M, Blumberg D, Dibley M . Identifying priority areas for longitudinal research in childhood obesity: Delphi technique survey. Int J Pediatr Obes. 2008; 3(2):120-2. DOI: 10.1080/17477160701830796. View

Hennissen L, Bakker M, Banaschewski T, Carucci S, Coghill D, Danckaerts M . Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine. CNS Drugs. 2017; 31(3):199-215. PMC: 5336546. DOI: 10.1007/s40263-017-0410-7. View

Chang Z, Ghirardi L, Quinn P, Asherson P, DOnofrio B, Larsson H . Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biol Psychiatry. 2019; 86(5):335-343. PMC: 6697582. DOI: 10.1016/j.biopsych.2019.04.009. View

Bisset M, Brown L, Bhide S, Patel P, Zendarski N, Coghill D . Practitioner Review: It's time to bridge the gap - understanding the unmet needs of consumers with attention-deficit/hyperactivity disorder - a systematic review and recommendations. J Child Psychol Psychiatry. 2023; 64(6):848-858. PMC: 10952204. DOI: 10.1111/jcpp.13752. View

Jacobson S, Ostlund P, Wallgren L, Osterberg M, Tranaeus S . TOP TEN RESEARCH PRIORITIES FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER TREATMENT. Int J Technol Assess Health Care. 2016; 32(3):152-9. DOI: 10.1017/S0266462316000179. View

Hinshaw S, Nguyen P, OGrady S, Rosenthal E . Annual Research Review: Attention-deficit/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions. J Child Psychol Psychiatry. 2021; 63(4):484-496. DOI: 10.1111/jcpp.13480. View

10.

Krinzinger H, Hall C, Groom M, Ansari M, Banaschewski T, Buitelaar J . Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence. Neurosci Biobehav Rev. 2019; 107:945-968. DOI: 10.1016/j.neubiorev.2019.09.023. View

11.

Nimmo-Smith V, Merwood A, Hank D, Brandling J, Greenwood R, Skinner L . Non-pharmacological interventions for adult ADHD: a systematic review. Psychol Med. 2020; 50(4):529-541. DOI: 10.1017/S0033291720000069. View

12.

Crisp J, Pelletier D, Duffield C, Adams A, Nagy S . The Delphi method?. Nurs Res. 1997; 46(2):116-8. DOI: 10.1097/00006199-199703000-00010. View

13.

Nussbaum N . ADHD and female specific concerns: a review of the literature and clinical implications. J Atten Disord. 2011; 16(2):87-100. DOI: 10.1177/1087054711416909. View

14.

Man K, Hage A, Banaschewski T, Inglis S, Buitelaar J, Carucci S . Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study. Lancet Psychiatry. 2023; 10(5):323-333. DOI: 10.1016/S2215-0366(23)00042-1. View

15.

Rudolph S, Hiscock H, Price A, Efron D, Sewell J, South M . What research questions matter to Australian paediatricians? National Delphi Study. J Paediatr Child Health. 2009; 45(12):704-10. DOI: 10.1111/j.1440-1754.2009.01598.x. View

16.

Kessler R, Adler L, Barkley R, Biederman J, Keith Conners C, Demler O . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006; 163(4):716-23. PMC: 2859678. DOI: 10.1176/ajp.2006.163.4.716. View